Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) EV to EBITDA (2014)

Updated

Xtl Biopharmaceuticals' (XTLB) EV to EBITDA stood at 895.02 in the quarter ended Jun 30, 2014, down 74.4% from the prior quarter.

Analysis

Xtl Biopharmaceuticals (XTLB) EV to EBITDA (2014) Analysis & Trends

On a TTM basis, Xtl Biopharmaceuticals' EV to EBITDA came in at 880.58 as of Jun 30, 2014.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 895.02
Mar 31, 2014 3,492.84
API Access

Xtl Biopharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=XTLB&period=max&api_key=YOUR_API_KEY